Figure 2.
Associations between XLOC_012370, clinicopathologic characteristics, and prognosis after surgery. (A) XLOC_012370 expression in different TNM stages of pancreatic cancer, stages I, II, and III (n = 13, n = 9, and n = 8, respectively). *P < 0.05. (B) XLOC_012370 expression in the lymph node metastasis-N0 group (N0, n = 7), -N1 group (N1, n = 9), and -N2 group (N2, n = 6). *P < 0.05. (C) Overall survival curve of the high-level and low-level group divided by XLOC_012370 expression. *P < 0.05.
